Measurement of testosterone in the diagnosis of hypogonadism in the ageing male

Clinical Endocrinology

Volumn 69, Issue 4, 2008, Pages 515-525

  Wheeler, M J ^a   Barnes, S C ^b  

^a Old Dairy   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGING; BLOOD SAMPLING; CIRCADIAN RHYTHM; DIAGNOSTIC ACCURACY; HUMAN; HYPOGONADISM; LABORATORY DIAGNOSIS; MALE; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; TESTOSTERONE BLOOD LEVEL;

AGING; BLOOD SPECIMEN COLLECTION; DIAGNOSTIC TECHNIQUES, ENDOCRINE; HUMANS; HYPOGONADISM; LIFE EXPECTANCY; MALE; REFERENCE VALUES; TESTOSTERONE;

EID: 51649087358     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03325.x     Document Type: Review

References (96)

1. Lunenfeld, B. (1999) Hormone replacement therapy in the aging male. The Aging Male, 2, 1 5.
2. Lunenfeld, B., Gooren, L.J.G., Morales, A. Morley, J.E., (eds) (2007) Textbook of Men's Health and Aging. Informa Healthcare UK Ltd, Andover, UK.
3. Bhasin, S. Buckwalter, J.G. (2001) Testosterone supplementation in older men: a rational idea whose time has not yet come. Journal of Andrology, 22, 718 731.
4. Vermeulen, A. (2001) Androgen replacement therapy in the aging male - a critical evaluation. Journal of Clinical Endocrinology and Metabolism, 86, 2380 2390.
5. Keles, K., Aydin, G., Basar, M.M., Hayran, M., Atalar, E., Orkun, S. Batislam, E. (2006) Endogenous sex steroids and bone mineral density in healthy men. Joint, Bone, Spine, 73, 80 85.
6. Szulc, P., Uusi-Rasi, K., Claustrat, B., Marchand, F., Beck, T.J. Delmas, P.D. (2004) Role of sex steroids in the regulation of bone morphology in men. The MINOS study. Osteoporosis Internal, 15, 909 917.
7. Amory, J.K., Watts, N.B., Easley, K.A., Sutton, P.R., Anawalt, B.D., Matsumoto, A.M., Bremner, W.J. Tenover, J.L. (2004) Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. Journal of Clinical Endocrinology and Metabolism, 89, 503 510.
8. Meier, C., Nguyen, T.V., Handelsman, D.J., Schindler, C., Kushnir, M.M., Rockwood, A.L., Meikle, A.W., Center, J.R., Eisman, J.A. Seibel, M.J. (2008) Endogenous sex hormones and incident fracture risk in older men: The Dubbo Osteoporosis Epidemiology Study. Archives of Internal Medicine, 168, 47 54.
9. Behre, H.M., Kliesch, S., Leifke, E., Link, T.M. Nieschlag, E. (1997) Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 82, 2386 2390.
10. Lunenfeld, B. (2007) Aging men-the challenge ahead. In : B. Lunenfeld, L.J.G. Gooren, A. Morales J. E. Morley eds. Textbook of Men's Health and Aging. Informa Healthcare, Andover, UK, pp. 465 471.
11. von Eckardstein, A. Wu, F.C.W. (2003) Testosterone and atherosclerosis. Growth Hormone and IGF Research, 13, S72 S84.
12. Crook, D. (2007) Atherosclerotic risk assessment of androgen therapy in aging men. In : B. Lunenfeld, L.J.G. Gooren, A. Morales J. E. Morley eds. Textbook of Men's Health and Aging. Informa Healthcare, Andover, UK, pp. 465 471.
13. Haddard, R.M., Kennedy, C.C., Caples, S.M., Tracz, M.J., Bolona, E.R., Sideras, K., Uraga, M.V., Erwin, P.J. Montori, V.M. (2007) Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placbo-controlled trials. Mayo Clinic Proceedings, 82, 29 39.
14. Rosano, G.M.C., Sheiban, I., Massaro, R., Pagnotta, P., Marazzi, G., Vitale, C., Mercuro, G., Volterrani, M., Aversa, A. Fini, M. (2007) Low testosterone levels are associated with coronary artery disease in male patients with angina. International Journal of Impotence Research, 19, 176 182.
15. Jankowska, E.A., Biel, B., Majda, J., Szklarska, A., Lopuszanska, M., Medras, M., Anker, S.D., Banasiak, W., Poole-Wilson, P.A. Ponikowski, P. (2006) Anabolic deficiency in men with chronic heart failure: Prevalence and detrimental impact on survival. Circulation, 114, 1829 1837.
16. Shabsingh, R., Katz, M., Yan, G. Makhsida, N. (2005) Cardiovascular issues in hypogonadism and testosterone therapy. American Journal of Cardiology, 96 (Suppl 67M 72M.
17. Isidori, A.M., Giannetta, E., Gianfrilli, D., Greco, E.A., Bonifacio, V., Aversa, A., Isidori, A., Fabbri, A. Lenzi, A. (2005) Effects of testosterone on sexual function in men: results of a meta-analysis. Clinical Endocrinology, 63, 381 394.
18. Annewieke, W., van den Beld, A.W., de Jong, F.H., Grobbee, D.E., Pols, H.A.P. Lamberts, S.W.J. (2000) Measures of bioavailable serum testosterone and estradiol and their relationship with muscle strength, bone density, and body composition in elderly men. Journal of Clinical Endocrinology and Metabolism, 85, 3276 3282.
19. O'Donnell, A.B., Travison, T.G., Harris, S.S., Tenover, J.L. McKinlay, J.B. (2006) Testosterone, dehydroepiandrosterone, and physical performance in older men: Results from the Massachusetts Male Aging Study. Journal of Clinical Endocrinology and Metabolism, 91, 425 431.
20. Schaap, L.A., Pluijm, S.M.F., Deeg, D.J.H., Penninx, B.W., Nicklas, B.J., Lips, P., Harris, T.B., Newman, A.B., Kritchevsky, S.B., Cauley, J.A., Goodpaster, B.H., Tylavsky, F.A., Yaffe, K. Visser, M. (2008) Low testosterone bevels and decline in physical performance and muscle strength in older men: findings from two prospective cohort studies. Clinical Endocrinology, 68, 42 50.
21. Fonda, S.J., Bertrand, R., O'Donnell, A., Longcope, C. McKinlay, J.B. (2005) Age, hormones, and cognitive functioning among middle-aged and elderly men: Cross-sectional evidence from the Massachusetts male aging study. Journals of Gerontology Series A - Biological Sciences and Medical Sciences, 60, 385 390.
22. Janowsky, J.S., Oviatt, S.K. Orwoll, E.S. (1994) Testosterone influences spatial cognition in older men. Behavioural Neuroscience, 108, 325 332.
23. Cherrier, M.M., Asthana, S., Plymate, S., Baker, L., Matsumoto, A.M., Peskind, E., Raskind, M.A., Brodkin, K., Bremner, W., Petrova, A., LaTendresse, S. Craft, S. (2001) Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology, 57, 80 88.
24. Nieschlag, E. (2006) Testosterone treatment comes of age: new options for hypogonadal men. Clinical Endocrinology, 65, 275 281.
25. Dobs, A.S., Meikle, A.W., Arver, S., Sanders, S.W., Caramelli, K.E. Mazer, N.A. (1999) Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 84, 3469 3478.
26. Swerdloff, R.S., Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A.M., Snyder, P.J., Weber, T.M., Lonstreth, J. Berman, N. (2000) Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 85, 4500 4510.
27. Salehian, B., Wang, C., Cunningham, G., Davidson, T., Mcdonald, V., Berman, N., Dudley, R.E., Ziel, F. Swerdloff, R.S. (1995) Pharmacokinetics, bioefficiency, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate: a clinical research centre trial. Journal of Clinical Endocrinology and Metabolism, 80, 3567 3575.
28. von Eckardstein, S. Nieschlag, E. (2002) Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study. Journal of Andrology, 23, 419 425.
29. Schubert, T., Minneman, T., Hubler, D., Rouskova, D., Christoph, A., Oettel, M., Ernst, M., Mellinger, U., Krone, W. Jockenhovel, F. (2004) Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel long-term treatment of men with hypogonadism. Journal of Clinical Endocrinology and Metabolism, 89, 5429 5434.
30. Findlay, J.C., Place, V. Snyder, P.J. (1989) Treatment of primary hypogonadism in men by the transdermal administration of testosterone. Journal of Clinical Endocrinology and Metabolism, 68, 369 373.
31. Gooren, L.J.G., Morales, A. Lunenfeld, B. (2007) Screening of the aging male. In : B. Lunenfeld, L.J.G. Gooren, A. Morales J.E. Morley eds. Textbook of Men's Health and Aging. Informa Healthcare UK Ltd, Andover, UK, pp. 63 95.
32. Bhasin, S., Cunningham, G.R., Hayes, F.J., Matsumoto, A.M., Snyder, P.J., Swerdloff, R.S. Montori, V.M. (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 91, 1995 2010.
33. Anonymous (2006) Testosterone replacement therapy for male aging: ASA position statement. Journal of Andrology, 27, 133 134.
34. Bain, J., Brock, G. Kuzmarov, I. (2007) Canadian Society for the Study of the Aging Male: response to Health Canada's position paper on testosterone treatment. Journal of Sexual Medicine, 4, 558 566.
35. Carruthers, M. (2004) Androgen Deficiency in the Adult Male: Causes, Diagnosis and Treatment. Taylor & Francis, London.
36. Carruthers, M. (2008) The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action. Journal of Sexual Medicine, 5, 998 1012.
37. Herold, D.A. Fitzgerald, R.L. (2003) Immunoassays for testosterone in women: better than a guess? Clinical Chemistry, 49, 1250 1251.
38. Sikaris, K., McLachlin, R.I., Kazlauskas, R., de Kretser, D., Holden, C.A., Handelsman, D.J. 2005) Reproductive hormone reference intervals for healthy fertile young men: Evaluation of automated platform assays. Journal of Clinical Endocrinology and Metabolism, 90, 5928 5936.
39. Anderson, D.C. (1974) Sex-hormone binding globulin. Clinical Endocrinology, 3, 69 96.
40. Toone, B.K., Wheeler, M. Fenwick, P.B.C. (1980) Sex hormone changes in male epileptics. Clinical Endocrinology, 12, 391 395.
41. Hammer, E.J. Astley, J.P. (1985) Increase in serum testosterone following contact with blood-cells. Annals of Clinical Biochemistry, 22, 539 540.
42. van der Molen, H.J. (1968) Interconversion of progesterone and 20-alpha-dihydroprogesterone and of androstenedione and testosterone in vitro by blood and erythrocytes. Acta Endocrinologica, 58, 419 444.
43. Wheeler, M.J. (2003) Factors that effect the interpretation of testosterone results. CPD Clinical Biochemistry, 2003, 80 85.
44. Bremner, W.J., Vitiello, M.V. Prinz, P.N. (1983) Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. Journal of Clinical Endocrinology and Metabolism, 56, 1278 1281.
45. Plymate, S.R., Tenover, J.S. Bremner, W.J. (1989) Circadian variation in testosterone, sex hormone-binding globulin and calculated non-sex hormone-binding globulin bound testosterone in healthy young and elderly men. Journal of Andrology, 10, 366 371.
46. Diver, M.J., Imtiaz, K.E., Ahmad, A.M., Vora, J.P. Fraser, W.D. (2003) Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clinical Endocrinology, 58, 710 717.
47. Solberg, H.E. (1986) Approved recommendation (1986) on the theory of reference values. 1. The concept of reference values. Clinica Chimica Acta, 165, 111 118.
48. Petitclerc, C. Solberg, H.E. (1987) Approved recommendation (1987) on the theory of reference values. 2. Selection of individuals for the production of reference values. Clinica Chimica Acta, 170, S1 S11.
49. Solberg, H.E. Petitclerc, C. (1988) Approved recommendation (1988) on the theory of reference values. 3. Preparation of individuals and collection of specimens for the production of reference values. Clinica Chimica Acta, 177, S3 S11.
50. Solberg, H.E. Stamm, D. (1991) Approved recommendation on the theory of reference values. 4. Control of analytical variation in production, transfer and application of reference values. Clinica Chimica Acta, 29, 531 535.
51. Solberg, H.E. (1987) Approved recommendation (1987) on the theory of reference values. 5. Statistical treatment of collected reference values - determination of reference limits. Clinica Chimica Acta, 170, S13 S32.
52. Dybkaer, R. Solberg, H.E. (1987) Approved recommendation (1987) on the theory of reference values. 6. Presentation of observed values related to reference values. Clinica Chimica Acta, 170, S33 S41.
53. Reed, A.H., Henry, R.J. Mason, W.B. (1971) Influence of statistical method used on the resulting estimate of reference range. Clinical Chemistry, 17, 275 284.
54. Taieb, J., Mathian, B., Millot, F., Patricot, M., Mathieu, E., Queyrel, N., Lacroix, I., Somma-Delpero, C. Boudou, P. (2003) Testosterone measurement by 10 immunoassays and isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women and children. Clinical Chemistry, 49, 1381 1395.
55. Boyce, M.J., Baisley, K.J., Clark, E.V. Warrington, S.J. (2004) Are published normal ranges of serum testosterone too high? Results of a cross-sectional survey of serum testosterone and luteinizing hormone in elderly men. British Journal of Urology International, 94, 881 885.
56. Wang, C., Catlin, D.H., Demers, L.M., Starcevic, B. Swerdloff, R.S. (2004) Measurement of total serum testosterone in adult men: Comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. Journal of Clinical Endocrinology and Metabolism, 89, 534 543.
57. Lamph, S., Wheeler, M. Halloran, S. (2003) Eight testosterone assays. MHRA Evaluation Report, MHRA 03127.
58. Lamph, S., Wheeler, M. Halloran, S. (2004) DPC Immulite and Immulite 2000. MHRA Evaluation Report, MHRA 04027.
59. Carey, R.N. (2006) User verification of performance for precision and trueness: approved guideline, EP15-A2. Clinical Laboratory Standards Institute, Pennsylvania, USA.
60. Velduis, J.D., Kolp, L.A., Rogol, A.D. Johnson, M.L. (1987) Physiological attributes of episodic testosterone secretion. Annals of the New York Academy of Sciences, 513, 507 508.
61. Mulligan, T., Iranmanesh, A., Gheorghiu, S., Godschalk, T. Veldhuis, J.D. (1995) Amplified nocturnal luteinizing hormone (LH) secretory burst frequency with selective attenuation of pulsatile (but not basal) testosterone secretion in healthy aged man: possible Leydig cell desensitization of endogenous LH signalling: a clinical research centre study. Journal of Clinical Endocrinology and Metabolism, 80, 3025 3031.
62. Wheeler, M.J. Lowy, C. (1987) Warning on serum testosterone measurement. Lancet, ii, 514 515.
63. Heald, A.H., Butterworth, A., Kane, J.W., Borzomato, J., Taylor, N.F., Layton, T., Kilpatrick, E.S. Rudenski A. (2006) Investigation into possible causes of interference in serum testosterone measurement in women. Annals of Clinical Biochemistry, 43, 189 195.
64. Warner, M.H., Kane, J.W., Atkin, S.L. Kilpatrick, E.S. (2006) Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone. Annals of Clinical Biochemistry, 43, 196 199.
65. Arlt, W. (2004) Concensus document on substitution therapy with DHEA in the elderly. Seminars in Reproductive Medicine, 22, 379 388.
66. Percheron, G., Hogrel, J.Y., Denot-Ledunois, S., Fayet, G., Forette, F., Baulieu, E.-E., Fardeau, F. Marini, J.-F. (2003) Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. Archives of Internal Medicine, 163, 720 727.
67. Yen, S.S.C., Morales, A.J. Khorram, O. (1995) Replacement of DHEA in aging men and women. Annals of the New York Academy of Sciences, 774, 128 142.
68. Swinkels, L.M.J.K., Ross, H.A. Benraad, T.J. (1978) A symmetric dialysis method for the determination of free testosterone in human plasma. Clinica Chimica Acta, 165, 341 349.
69. Pardridge, W.M. (1986) Receptor-mediated peptide transport through the blood-brain barrier. Endocrine Reviews, 7, 314 330.
70. Meikel, C.M. (1989) The free hormone hypothesis. Endocrine Reviews, 10, 232 274.
71. Ekins, R. (1990) Measurement of free hormones in blood. Endocrine Reviews, 11, 5 46.
72. Cumming, D.C. Wall, S.R. (1985) Non-sex hormone-binding globulin-bound testosterone as a marker of hyperandrogenism. Journal of Clinical Endocrinology and Metabolism, 61, 873 876.
73. Kapoor, D., Clarke, S., Channer, K.S. Jones, T.H. (2007) Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. International Journal of Andrology, 30, 500 507.
74. Emadi-Konjin, P., Bain, J. Bromberg, I.L. (2003) Evaluation of an algorithm for calculation of serum 'bioavailable' testosterone (BAT). Clinical Biochemistry, 36, 591 596.
75. Giton, F., Urien, S., Born, C., Tichet, J., Guechot, J., Callebert, J., Bronsard, F., Raynaud, J.P. Fiet, J. (2007) Determination of bioavailable testosterone [non-sex hormone-binding globulin (SHBG)-bound testosterone] in a population of healthy French men: influence of androstenediol on testosterone binding to SHBG. Clinical Chemistry, 53, 2160 2168.
76. Kratzik, C.W., Schatzl, G., Lackner, J.E., Lunglmayr, G., Brandstatter, N., Rucklinger, E. Huber, J. (2007) Mood changes, body mass index and bioavailable testosterone in healthy men: results of the Androx Vienna Municipality Study. British Journal of Urology International, 100, 614 618.
77. Sandberg, A.A., Slaunwhite, W.R. Antoniades, H.N. (1957) The binding of steroids and steroid conjugates to human plasma proteins. Recent Progress in Hormone Research, 13, 209 267.
78. Forest, M.G., Rivarola, M.A. Migeon, C.J. (1968) Percentage binding of testosterone, androstenedione and dehydroepiandrosterone in plasma. Steroids, 12, 323 343.
79. Viahos, I., MacMahon, W., Sgoutas, D., Bowers, W., Thompson, J. Trawick, W. (1982) An improved ultrafiltraton method for determining free testosterone in serum. Clinical Chemistry, 28, 2286 2291.
80. Fisher, R.A., Anderson, D.C. Burke, C.W. (1974) Simultaneous measurement of unbound testosterone and estradiol fractions in undiluted plasma at 37 °C by steady-state gel filtration. Steroids, 24, 809 824.
81. Wheeler, M.J. Nanjee, M.N. (1985) A steady-state gel filtration method on micro-columns for percentage free testosterone in serum. Annals of Clinical Biochemistry, 22, 185 189.
82. Vermeulen, A., Verdonck, L. Kaufman, J.M. (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism, 84, 3666 3672.
83. Sodergard, R., Backstrom, T., Shanbhag, V. Carstensen, H. (1982) Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. Journal of Steroid Biochemistry, 16, 801 810.
84. Dunn, J.F., Nisula, B.C. Rodbard (1981) Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. Journal of Clinical Endocrinology and Metabolism, 53, 58 68.
85. Nanjee, M.N. Wheeler, M.J. (1985) Plasma free testosterone: is an index sufficient? Annals of Clinical Biochemistry, 22, 387 390.
86. Morris, P.D., Malkin, C.J., Channer, K.S. Jones, T.H. (2004) A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men. European Journal of Endocrinology, 151, 241 249.
87. Ly, L.P. Handelsman, D.J. (2005) Empirical estimation of free testosterone from testosterone and sex-hormone binding globulin immunoassays. European Journal of Endocrinology, 105, 471 478.
88. Blight, L.F., Judd, S.J., White, G.H. (1989) Relative diagnostic value of serum non-SHBG testosterone, free androgen index and free testosterone in the assessment of mild to moderate hirsutism. Annals of Clinical Biochemistry, 26, 311 316.
89. Winters, S.J., Kelley, D.E. Goodpaster, B. (1998) The analog free testosterone assay: are the results clinically useful? Clinical Chemistry, 44, 2178 2182.
90. Rosner, W. (2001) An extraordinarily inaccurate assay for free testosterone is still with us. Journal of Clinical Endocrinology and Metabolism, 86, 2903.
91. Fritz, K.S., McKean, A.J.S., Nelson, J.C. Wilcox, R.B. (2008) Analog-based free testosterone test results linked to total testosterone concentrations, not free testosterone concentrations. Clinical Chemistry, 54, 512 516.
92. Martinez-Jabaloyas, J.M., Quelpo-Zaraoza, A., Gil-Salom, M. Chuan-Nuez, P. (2006) Evaluation of an immunoassay kit to measure free testosterone. Actas Urologicas Espanolas, 30, 598 601.
93. Manni, A., Pardridge, W.M., Cefalu, W., Nisula, B.C., Bardin, C.W., Santer, S.J. Santen, R.J. (1985) Bioavailability of albumin-bound testosterone. Journal of Clinical Endocrinology and Metabolism, 61, 705 710.
94. Déchaud, H., Lejeune, H., Garoscio-Cholet, M., Mallein, R. Pugeat, M. (1989) Radioimmunoassay of testosterone not bound to sex-steroid protein in plasma. Clinical Chemistry, 35, 1609 1614.
95. Ho, C.K.M., Stoddart, M., Walton, M., Anderson, R.A. Beckett, G.J. (2006) Calculated free testosterone in men: comparison of four equations and with free androgen index. Annals of Clinical Biochemistry, 43, 389 397.
96. De Ronde, W., van der Schouw, Y.T., Pols, H.A.P., Gooren, L.J.G., Muller, M., Grobbee, D.E. de Jong, F.H. (2006) Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms. Clinical Chemistry, 52, 1777 1784.